Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
76 Cards in this Set
- Front
- Back
Glucose
|
main energy source for our body
Brain is dependent on it |
|
Glycogen
|
Storage molecule for excess glucose
|
|
Glycogenolysis
|
Breakdown of glycogen into glucose
Occurs during low blood glucose levels |
|
Gluconeogenesis
|
Production of glucose from new sources
|
|
Insulin
|
Produced by the beta cells as proinsulin
Increases: glucose uptake into cells, synthesis of protein and TGs and fatty acids Decreases: breakdown of glycogen and fat and protein, fatty acid oxidation, gluconeogenesis |
|
Amylin
|
Produced by beta cells and co-secreted with insulin
decreases glucagon and slows gastric emptying |
|
Glucagon-like Peptide 1 (GLP-1)
|
gut hormone released in response to food -- stimulates insulin secretion
|
|
Selective sodium-dependent glucose cotransporter (SGLT-2)
|
helps the kidney reabsorb glucose
if inhibited - allows glucose to pass into the urine |
|
Factors Decrease Blood glucose
|
1. insulin
2. Excess DM meds 3. other meds 4. Lack of food 5. exercise 6. increased alcohol intake 7. decreased hepatic/renal function |
|
Factors increase blood glucose
|
1. Counter-regulatory hormones
2. Insufficient DM meds 3. Other meds 5. Excess foods 6. Exercise 7. Illness 8. stress |
|
Medications that Increase Blood Glucose
|
1. Corticosteroids
2. Thiazides 3. Protease Inhibitors (Ritonavir) 4. Antipsychotics 5. Phenytoin 6. Nicotinic Acid |
|
Medications that Decrease Blood Glucose
|
1. DM meds
2. Antimalarial (quinine) 3. Antibiotics 4. Ranolazine 5. High dose salicylates |
|
Fasting Plasma Glucose (FPG)
|
No caloric intake for 8 hours or more
|
|
Random Plasma Glucose (RPG)
|
Any time of day without regard to last meal
|
|
Oral Glucose Tolerance Test (OGTT)
|
Take 75g glucose drink and then glucose is measured 2 hours later
|
|
Postprandial Glucose (PPG)
|
Measured 2 hours after beginning of last meal
|
|
Hemoglobin A1c
|
*GOLD STANDARD FOR LONG TERM MONITORING*
Average glucose level over the past 2-3 months |
|
a) FPG for diagnosis of Diabetes
b) Goals of therapy for FPG |
a) 126 or higher
b) 70-130 mg/dL |
|
a) RPG for diagnosis of diabetes
|
200 mg/dL plus symptoms of diabetes such as polyuria, polydipsia, polyphagia
|
|
a) A1c for diagnosis of diabetes
b) Goals of therapy for A1c |
a) 6.5% or greater
b) less than 7% |
|
a) OGTT for diagnosis of diabetes
|
200 mg/dL or higher
|
|
Goal of therapy with Post Prandial Glucose
|
less than 180 mg/dl
|
|
Non-glycemic goals of diabetes
|
BP: <140/80
LDL: <100 mg/dL (optional <70) |
|
Medical Nutrition Therapy
|
Nutrition assessment generally provided by registered dietitians to evaluate a patient's food intake, metabolic status, lifestyle, and readiness for change
Personlized |
|
Goals of MNT for at risk patients
|
reduce the risk of T2DM and CV disease by encouraging regular physical activity and weight loss
|
|
Goals of MNT for patient with diabetes
|
1. prevent and treat chronic complications by attaining and maintaining optimal metabolic outcomes (BG, A1c, lipids, BP, weight)
2. Healthy food choices and physical activity 3. Adress individual needs (personal and cultural preference) |
|
Protein
|
Role: form/help repair body tissues
Found: meat, dairy, eggs, legumes Impact on glucose: acute increase in insulin but doesn't increase circulating glucose |
|
Fat
|
Role: provide essential fatty acids & carry fat-soluble vitamins
Found: oils, margarine, nuts, animal products Impact on glucose: slows glucose absorption delaying peak |
|
Carbohydrates
|
Role: provide sources of fuel for the body
Found: breads, pasta, rice, cereal, fruit, sweets Impact on glucose: most direct on glucose levels |
|
MNT factors that affect blood glucose response
|
1. amount of carbs
2. type of sugar or starch 3. processing (grinding, rolling, pressing) 4. food prep 5. physical form (juice vs whole) 6. ripeness |
|
Methods to monitor carb consumption
|
1. Exchanges
2. Carb counting 3. plate method 4. Glycemic Index |
|
Exchanges for MNT
|
Patients taught what quantity of a carb-containing food amounted to 10g, 12g, 15g
|
|
Carb counting for MNT
|
Meal planning method that involves keeping total carb intake at each meal consistent from day to day
|
|
Plate Method for MNT
|
Suggestive of portions
Plate is divided into sections |
|
Glycemic Index for MNT
|
system for ranking carb foods according to their effect on postprandial glycemia
ranked on a scale of 0-100% when compared to blood glucose response of 50g of glucose |
|
Glucose change at beginning of exercise
|
myosin ATPase breaks down ATP to produce energy
Carbs, fats, proteins are broken down |
|
Glucose change 5-10 minutes into exercise
|
sustained movement allows carbs, fats, proteins to continually recharge
muscle glycogen breakdown decreases |
|
Glucose changes 20 minutes or more into exercise
|
muscles' glycogen stores are depleted
blood glucose maintained by glycogenolysis |
|
Exercise's role in diabetes
|
1. improve blood glucose control
2. reduce CV risk factors 3. weight loss 4. improve well-being |
|
Type 1 diabetes
|
immune-mediated process that leads to destruction of beta cells - deficiency of insulin
|
|
Clinical presentation of Type 1 diabetes
|
1. incidence peaks at 10-14yo
2. 3 P's: polyuria, polyphagia, polydipsia 3. weight loss 4. fatigue 5. DKA |
|
Are ADA goals higher or lower for children?
|
Higher goals are set
|
|
Non-pharmacological treatment of Type 1 diabetes
|
1. MNT
2. Exercise 3. SMBG 4. Education 5. Psychosocial support |
|
Insulin for Type 1 Diabetes
|
essential for all patients with T1DM; initiate promptly after diagnosis
|
|
MOA for insulin
|
replaces insulin deficiency -- glucose uptake by cells with beneficial effects on protein, carbs, fat metabolism
|
|
Rapid Acting Insulin (Bolus)
|
1. Lispro (Humalog)
2. Aspart (Novolog) 3. Glulisine (Apidra) |
|
Short Acting Insulin (Bolus)
|
Regular (Humulin R, Novolin R)
|
|
Intermediate Acting (Basal)
|
NPH (Humulin N, Novolin N)
|
|
Long Acting (Basal)
|
1. Glargine (Lantus)
2. Detemir (Levemir) |
|
Storage and stability of insulin
|
Unopened: refridgerated
Opened: refrigerated Vial: 28 days (Levemir 42 days) Pen: 10-28 day (Levemir 42 days) |
|
When should rapid insulin be given
|
15 minutes or less before a meal
|
|
short acting insulin should be given
|
30-45 minutes before a meal
|
|
Intermediate and long acting insulin should be given
|
1-2 times per day
|
|
ADRs of Insulin
|
1. Hypoglycemia
2. Weight Gain 3. Lipodystrophy |
|
Initial Dosing of Insulin in Type 1 diabetes
|
Total Daily Dose (TDD)
Weight based: 0.5-1units/kg or Sliding Scale |
|
Regimens of Insulin
|
1. Split mix regimen
2. Basal-bolus |
|
Split mix regimen of insulin
|
**Intermediate acting w/ short acting
1. 2/3 of TDD given in morning, 1/3 given in evening 2. 2:1 ratio (I:S) for each dose OR 2:1 ratio I:S in morning and 1:1 ratio (I:S) in evening |
|
a) advantages of Split Mix
b) disadvantages |
a) fewer injections per day
b) adhere to strict timing of meals and injections less physiologically accurate |
|
Basal-Bolus Regimen
|
1. 50% TDD (Long acting - once daily; intermediate - 2/3 in morning, 1/3 in evening)
2. 50% TDD (split equally OR 20% breakfast, 15% lunch, 15% dinner) |
|
a) advantages to basal-bolus
b) disadvantages |
a) tighter control, flexibility, mimics real life
b) up to 5 injections per day, increased cost |
|
How to adjust basal insulin
|
adjust based on fasting blood sugar
10-20% of TDD |
|
how to adjust bolus insulin
|
adjust based on postprandial blood sugar
1-2 unit increments |
|
How to make advanced adjustments of bolus insulin
|
1) Insulin:Carb ratio (tailor to specific meal)
2) Insulin Sensitivity Factor ("corrects" elevated glucose) |
|
Insulin:Carb Ratio formula
|
500 / TDD = grams of carbs covered by 1 unit of rapid or short insulin
|
|
Insulin Sensitivty Factor Formula
a) rapid insulin b) short acting |
a) 1800/TDD
b) 1500/TDD |
|
Early Morning Hyperglycemia
|
1. Somogyi Effect
2. Dawn Phenomenon |
|
Somogyi Effect
|
1. hypoglycemia during the night -- increased secretion of counter-regulatory hormones -- hyperglycemia in the morning
3am glucose = LOW |
|
Possible adjustments for Somogyi effect
|
1. decrease PM dose of intermediate insulin
2. move PM dose to later in the evening 3. Switch from intermediate to long acting |
|
Dawn Phenomenon
|
morning hyperglycemia due to natural increase of glucose between 4-8am
3am glucose = NORMAL - SLIGHTLY HIGH |
|
Dosing with Insulin Pump
|
TDD = 0.5-1 unit/kg
Decrease TDD by 10-30% = Pump TDD Basal: 50% of pump TDD and divide by 24 hours Bolus: 50% of pump TDD |
|
a) advantages of insulin pump
b) disadvantages |
a) improved glycemic control, very precise amounts, more flexibility, reduced hypoglycemia
b) cost, skin infections, DKA |
|
MOA of pramlintide
|
mimics endogenous amylin -- slows gastric emptying, decreases glucagon secretion, increases feeling of fullness
decreases initial postprandial spike |
|
Dosing for T1DM of Pramlintide (Symlim)
|
Initial: 15mcg subq prior to major meals
titrate up in 15mcg increments if no nausea x3days Maintenance: 30-60mcg subq prior to major meals |
|
Decrease pre-prandial rapid acting/short acting insulin by 50%
|
Very important note about insulin if patient is on pramlintide (Symlin)
|
|
ADRs of pramlintide (Symlin)
|
1) Hypoglycemia (within 3 hours of injection)
2) Nausea |
|
Monitoring for T1DM
|
1. Urine Ketones
2. SMBG (6-8 times per day) 3. A1c (q3-6 months) |